Novo pushes new obesity care approach
A global drugmaker is seeking to reshape how Filipinos understand and treat obesity, launching a nationwide initiative alongside a new prescription therapy…
· 1 MIN READ
Daily TribuneTopic
A global drugmaker is seeking to reshape how Filipinos understand and treat obesity, launching a nationwide initiative alongside a new prescription therapy…
· 1 MIN READ
A global drugmaker is seeking to reshape how Filipinos understand and treat obesity, launching a nationwide initiative alongside a new prescription therapy…
· 2 MIN READ
As many as 1.5 million patients in the United States may now be using compounded versions of popular weight-loss drugs , highlighting how lower-cost…
· 2 MIN READ
European regulators have issued a warning that Novo Nordisk’s popular weight-loss and diabetes medications — Wegovy, Ozempic, and Rybelsus — may be associated…
· 2 MIN READ
Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Wednesday its net profit rose 21% to 100…
· 1 MIN READ